T. T. van Duijl, T.T.

Post-doctoral researcher
Molecular Hematology, Sanquin Research, Asterdam, The Netherlands
Amsterdam, Noord-Holland, Netherlands

Tirsa van Duijl has completed her PhD at the department of Clinical Chemistry and Laboratory Medicine, Leiden University Medical Center, focusing on quantitative protein mass spectrometry for biomarker translation in the clinical laboratory. Alongside her PhD, Dr van Duijl has presented at various scientific conferences. After gaining her PhD in 2023, she started her current position as a postdoctoral researcher in the proteomics group at the department of Molecular Hematology of Sanquin Research (Amsterdam, The Netherlands). Her multi-proteomics research projects focuses on molecular footprinting of hemostatic disorders, including bleeding disorders of unknown cause.

Presentation(s):

• PB0278 - Current practice regarding Bleeding Disorder of Unknown Cause (BDUC) in the Netherlands: a national survey

  Sunday, June 23, 2024
  13:45 – 14:45 ICT

• PB0285 - Diagnosing and treating Bleeding Disorder of Unknown Cause: an illustrated review on current practice and future directions

  Sunday, June 23, 2024
  13:45 – 14:45 ICT

• OC 27.1 - Dominant negative effects of Gln50Arg mutation in the EGF-1 domain of factor IX causes severe Hemophilia B affecting factor IX replacement therapy

  Sunday, June 23, 2024
  14:45 – 15:00 ICT

• OC 37.1 - Advanced hemostasis testing by quantitative proteomics

  Monday, June 24, 2024
  09:30 – 09:45 ICT

• PB0851 - Quantitative mass spectrometry-based monitoring of site-specific citrullination of fibrinogen

  Monday, June 24, 2024
  13:45 – 14:45 ICT